ImmuneOnco Biopharmaceuticals (Shanghai) Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

SHSC:1541 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
13 Nov 24	SellHK$54,518,800	Lapam Capital	Company	6,251,800	HK$8.72
24 Oct 24	SellHK$18,673,509	Shanghai Yongkan Investment Management Co., Ltd.	Company	3,165,000	HK$5.90
23 Oct 24	SellHK$23,355,349	Shanghai Yongkan Investment Management Co., Ltd.	Company	4,061,800	HK$5.75
21 Oct 24	SellHK$9,533,021	Shanghai Yongkan Investment Management Co., Ltd.	Company	1,675,400	HK$5.69
04 Oct 24	SellHK$10,743,652	Eli Lilly Investment Consulting (Shanghai) Co., Ltd.	Company	1,432,200	HK$7.50
02 Oct 24	SellHK$12,000,007	Eli Lilly Investment Consulting (Shanghai) Co., Ltd.	Company	2,000,000	HK$6.00
25 Sep 24	SellHK$12,502,390	Eli Lilly Investment Consulting (Shanghai) Co., Ltd.	Company	2,468,000	HK$5.07

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 19 shareholders own 68.31% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
18.8%	Tian Wenzhi	70,182,990	HK$534.8m	0%	no data
12.2%	ImmuneOnco Biopharmaceuticals (Shanghai) Inc. , ESOP	45,701,100	HK$348.2m	-5.49%	no data
8.54%	Shanghai Yongkan Investment Management Co., Ltd.	31,939,990	HK$243.4m	-24.6%	no data
5.35%	Lyfe Capital	20,014,593	HK$152.5m	25%	22.6%
5.15%	Lapam Capital	19,263,240	HK$146.8m	0%	11.52%
3.7%	Greater Bay Area Homeland Investments Limited	13,854,690	HK$105.6m	0%	95.91%
3.35%	LAV Investment Adviser Limited	12,542,805	HK$95.6m	0%	10.6%
2.9%	Shanghai Zhangjiang Science&Technology Venture Capital Co., Ltd	10,862,055	HK$82.8m	0%	19.99%
2.57%	Shanghai Milestone Asset Management Co., Ltd.	9,631,620	HK$73.4m	0%	10.96%
1.93%	Shanghai Liyi Investment Management Partnership (Limited Partnership)	7,214,085	HK$55.0m	-50%	5.83%
1.27%	Shanghai Lineng Asset Management Co., Ltd.	4,742,630	HK$36.1m	0%	16.29%
1.25%	Eli Lilly Investment Consulting (Shanghai) Co., Ltd.	4,694,370	HK$35.8m	-58.4%	0.88%
0.58%	Milestone Asset Management (Cayman) Co., Ltd.	2,185,020	HK$16.6m	0%	no data
0.45%	Nanjing Xingjian Ruiying Equity Investment Partnership (Limited Partnership)	1,697,445	HK$12.9m	0%	no data
0.2%	Chen Fei	753,840	HK$5.7m	-50%	no data
0.078%	Bosera Asset Management Co., Ltd.	291,800	HK$2.2m	0%	no data
0.0057%	China Asset Management Co. Ltd.	21,431	HK$163.4k	0%	no data
0.00027%	Yiquan Cheng	1,000	HK$7.7k	0%	no data
0.00016%	E Fund Management Co., Ltd.	600	HK$4.6k	0%	no data